In older adults, a plain daily multivitamin has better randomized evidence for cognition than almost any nootropic stack. In the COSMOS-Mind trial, about 2,200 adults aged 65 and over took a multivitamin or placebo for three years, and the multivitamin group scored slightly higher on a global cognition composite, an effect the investigators equated to roughly two years of age-related decline. The effect was small, and there is no equivalent trial in younger adults. Most nootropic stacks have no trial of the stack itself, and several of their individual ingredients have failed large trials.
What the multivitamin trials found
The COSMOS program tested a daily multivitamin-mineral against placebo in older adults in several cognitive substudies. The COSMOS-Mind substudy and the meta-analysis of the three COSMOS cognitive studies found a small but consistent benefit on global cognition and episodic memory over about three years. Two cautions apply: the effect size is modest (a few hundredths of a standard deviation on a composite score), and the participants were older adults, many of them on usual diets, so the result does not automatically transfer to a 35-year-old with brain fog. The cocoa-flavanol arm of the same program found no cognitive effect; see cocoa flavanols and memory.
Side by side: multivitamin versus common stack ingredients
| Option | Best evidence | Size and certainty |
|---|---|---|
| Daily multivitamin (older adults) | COSMOS-Mind and meta-analysis of three COSMOS studies, 3 years | Small, replicated across substudies |
| Bacopa monnieri | Meta-analysis of 9 randomized trials, 518 people, 12+ weeks | Two small improvements; slow to appear (dosage) |
| L-theanine | Meta-analysis of 16 trials | Faster choice reaction time about an hour after a dose (evidence) |
| Creatine | Meta-analyses of 8 and 16 trials | Small memory benefit, strongest under stress (dosage) |
| Ginkgo biloba | Cochrane review and two large prevention trials | No convincing benefit; bleeding risk (trials) |
| Omega-3 | Cognitive trials at 500–2,000 mg a day for 6–24 months | Mostly null in healthy older adults (dosage) |
| Vitamin D | Randomized trials including VitaMIND | No cognitive benefit in people with adequate levels (evidence) |
| Proprietary “brain blend” | Usually none for the blend itself | Unknowable doses (why) |
Why a stack is harder to justify than one simple pill
- Nobody tested the stack. Trials test single ingredients at specific doses. A formula that combines six of them at a fraction of each dose is not the same experiment.
- Interactions multiply. Every ingredient you add is another interaction to check; see nootropics and antidepressants and ginkgo and blood thinners.
- Labels are unreliable. Hidden doses, unverified purity and, in some products, unapproved drugs are documented; see what third-party testing certifies and unapproved nootropic drugs.
A sensible order of operations
- Rule out causes that supplements cannot fix: sleep debt, alcohol, medication effects, low B12 or iron, thyroid problems. Start with the brain fog red flags and what to do when tests are normal.
- Fix the large levers first: sleep timing, regular movement, and eating regularly. See sleep and memory and exercise and cognition.
- If you are an older adult and want to try something with randomized support, ask a clinician whether a standard multivitamin suits you. Do not take it as a cure; the effect in trials was small.
- If you still want a nootropic, pick one ingredient with a trial-matched dose, use it for the trial duration, and keep a simple log. Read whether nootropics actually work first.
Related guides
- The case against brain supplements
- Nine ingredients that signal a bad brain supplement
- How we rate the evidence
- Supplements that cause brain fog
Sources
- COSMOS-Mind: multivitamin and cocoa extract effects on cognition, Alzheimer’s & Dementia
- COSMOS-Clinic and meta-analysis of the three COSMOS cognitive studies, Am J Clin Nutr
- COSMOS trial: published results
- Kongkeaw et al., meta-analysis of Bacopa monnieri randomized controlled trials, J Ethnopharmacol 2014
- Cochrane review: Ginkgo biloba for cognitive impairment and dementia (2026)
- L-theanine systematic review and meta-analysis, Nutrition Reviews 2025
- Prokopidis et al., creatine supplementation and memory, Nutrition Reviews 2023
- VitaMIND: vitamin D supplementation and cognition, JAMDA 2025
These statements have not been evaluated by the Food and Drug Administration. Nothing here is intended to diagnose, treat, cure or prevent any disease.
This article is information, not medical advice. Talk to a doctor or pharmacist about your own situation, especially if you take prescription medication.

